MedPath

湖北美林药业有限公司

Ownership
-
Established
2010-04-12
Employees
-
Market Cap
-
Website
www.merriclin.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

60

NMPA:60

Drug Approvals

Glycerol Fructose and Sodium Chloride Injection

Product Name
甘油果糖氯化钠注射液
Approval Number
国药准字H20254205
Approval Date
May 20, 2025
NMPA

Isoniazid Injection

Product Name
异烟肼注射液
Approval Number
国药准字H20244651
Approval Date
Aug 5, 2024
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20244080
Approval Date
Jun 18, 2024
NMPA

Doxofylline Injection

Product Name
多索茶碱注射液
Approval Number
国药准字H20244081
Approval Date
Jun 18, 2024
NMPA

Norfloxacin Eye Drops

Product Name
诺氟沙星滴眼液
Approval Number
国药准字H20093768
Approval Date
Jun 17, 2024
NMPA

Ciprofloxacin Lactate Eye Drops

Product Name
乳酸环丙沙星滴眼液
Approval Number
国药准字H20093764
Approval Date
Jun 17, 2024
NMPA

CompoundAminoAcidGranules(9AA)

Product Name
复方氨基酸颗粒(9AA)
Approval Number
国药准字H20194037
Approval Date
Mar 1, 2024
NMPA

Ciprofloxacin Lactate and Sodium Chloride Injection

Product Name
乳酸环丙沙星氯化钠注射液
Approval Number
国药准字H42020843
Approval Date
Sep 11, 2023
NMPA

Trapidril Tablets

Product Name
曲匹地尔片
Approval Number
国药准字H20184139
Approval Date
Jul 31, 2023
NMPA

Aciclovir Eye Drops

Product Name
阿昔洛韦滴眼液
Approval Number
国药准字H20083664
Approval Date
Apr 23, 2023
NMPA
  • Prev
  • 1
  • 2
  • 3
  • 4
  • 5
  • 6
  • Next

Clinical Trials

No trials found

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.